The homeopathic approach to the treatment of symptoms of oestrogen withdrawal in breast cancer patients. A prospective observational study
Received25 September 2002
revised06 January 2003
accepted24 March 2003
21 December 2017 (online)
This paper reports on an investigation of the homeopathic approach to the management of symptoms of oestrogen withdrawal in women with breast cancer. Forty-five patients entered the study. The most common presenting symptoms were hot flushes (HF) ( n = 38), mood disturbance ( n = 23), joint pain ( n = 12), and fatigue ( n = 16). Other symptoms included sleeplessness, reduced libido, weight gain, cystitis, vaginal dryness and skin eruptions. The active intervention was an individualised homeopathic medicine. Forty women (89%) completed the study. Significant improvements in mean symptom scores were seen over the study period and for the primary end-point ‘the effect on daily living’ scores. Symptoms other than HF such as fatigue and mood disturbance appear to be helped. Significant improvements in anxiety, depression and quality of life were demonstrated over the study period. The homeopathic approach appears to be clinically useful in the management of oestrogen withdrawal symptoms in women with breast cancer whether on or off Tamoxifen and improves mood disturbance. A placebo-controlled trial would be the next stage in this line of inquiry.
- 1 Carpenter JS, Andrykowski MA, Cordova M, et al. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 1998; 82: 1682–1691.
- 2 Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993; 307: 836–840.
- 3 Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994; 331: 347–352.
- 4 Goldberg RM, Loprinzi CL, O’Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994; 12: 155–158.
- 5 Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6–11.
- 6 Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059–2063.
- 7 Bekkering GM van den Bosch. Bedriegt Schone Schijn? Een Onderzoek Om De Gerapporteerde Werking Van Een Homeopathisch Middel Te Objectiveren. Huisarts en Wetenschap 1993; 36: 414–415.
- 8 Gautier J. Essai Therapeutique Comparitif De L’action De La Clonidine et Du Lachesis Mutans Dans Le Traitement des Bouffes et De Lia Chaleur De La Menopause. Thesis, Universite de Bordeaux, 1983.
- 9 Clover A. Homeopathic treatment of hot flushes: a pilot study. Homp 2002; 91: 75–79.
- 10 Thompson EA, Reillly D. The homeopathic approach to symptom control in the cancer patient: a prospective observational study. Palliat Med 2002; 16: 227–233.
- 11 Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ 1996; 312: 1016–1020.
- 12 Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed) 1986; 293: 1331–1334.
- 13 Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999; 340: 1733–1739.
- 14 Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behaviour: a survey. Cancer 2000; 89: 873–880.
- 15 Clover A, Last P, Fisher P, Wright S, Boyle H. Complementary cancer therapy: a pilot study of patients, therapies and quality of life. Complement Ther Med 1995; 3: 129–133.
- 16 Canney P, Hatton MQ. The prevalence of menopausal symptoms in patients treated for breast cancer. Clin Oncol (R Coll Radiol) 1994; 6: 297–299.